KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Globus Medical (GMED) Shares Issued (2016 - 2026)

Globus Medical filings provide 15 years of Shares Issued readings, the most recent being $62.8 million for Q4 2025.

  • On a quarterly basis, Shares Issued fell 9.42% to $62.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $89.8 million, a 18.73% decrease, with the full-year FY2025 number at $89.8 million, down 18.73% from a year prior.
  • Shares Issued hit $62.8 million in Q4 2025 for Globus Medical, up from $11.1 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $69.3 million in Q4 2024 to a low of $1.0 million in Q4 2023.
  • Median Shares Issued over the past 5 years was $10.1 million (2021), compared with a mean of $15.9 million.
  • Biggest five-year swings in Shares Issued: plummeted 93.29% in 2023 and later surged 6561.83% in 2024.
  • Globus Medical's Shares Issued stood at $3.6 million in 2021, then skyrocketed by 334.69% to $15.5 million in 2022, then plummeted by 93.29% to $1.0 million in 2023, then surged by 6561.83% to $69.3 million in 2024, then dropped by 9.42% to $62.8 million in 2025.
  • The last three reported values for Shares Issued were $62.8 million (Q4 2025), $11.1 million (Q3 2025), and $4.7 million (Q2 2025) per Business Quant data.